Jaguar Health Inc (JAGX)
$1.85
0.09 (4.64%)
JAGX Stock Quote Delayed 30 Minutes
Jaguar Health Has Enough Short-Term Catalysts To Make It Interesting
It's easy to dismiss JAGX stock as just another beneficiary of the equity bull market. However, Jaguar Health has made significant strides during the last year.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
16.16M
PE Ratio
-0.04
EPS
-51.75
Volume (Avg. Vol.)
4.38M
Day's Range
1.83 - 1.91
52-Week Range
0.19 - 4.47
Dividend & Yield
N/A (N/A)
JAGX Stock Predictions, Articles, and Jaguar Health Inc News
Is the Parabolic Rise of JAGX Stock Too Good to Be True?
JAGX stock has risen dramatically on positive sentiment about the potential for an expanded market for the company's core Mytesi drug.
Jaguar Health Is on a Noble Mission But the Stock Needs a Nudge
Jaguar Health is doing the right thing while JAGX stock is on the skids. It is falling into support, so there could be relief coming.
Is Jaguar Health Ready to Bounce Back From a Lousy February?
Jaguar Health did not have a good February. Down 25% through Feb. 25, it might be time to give up on JAGX stock despite SPAC spinoff.
Jaguar Health Has Promise, But It’s Not a Good Investment Yet
JAGX stock needs to prove the effectiveness of its drug candidates before investors can consider jumping on its bandwagon.
JAGX Stock: What to Know as SPAC News Sends Jaguar Health Soaring
JAGX stock is on the move today after the popular company announced it had signed a memorandum of understanding for a SPAC deal.
Hold Jaguar Health Stock for SPAC Spin-Off and Covid-19 Connection
JAGX stock holders must weigh the impact of an intriguing European SPAC and a potential treatment option for Covid-19 long-haul patients.
Jaguar Health Has a Strong Outline, But the Story Is Unclear
The 12-month, 300% gain with JAGX stock has a lot of headline news. There’s a lot to like, but will Jaguar be able to build on its gains?
Jaguar Health Isn’t a Healthy Investment, but It Could Be a Profitable One
Likely, no one would suggest that JAGX stock is a fundamentally sound investment. But the current market environment makes shares a compelling short-term trade.
Jaguar Health Stock Remains a Speculative Investment At Best
Jaguar Health stock is a speculative investment at best. JAGX stock is hard to nail down as it’s hard to understand its numerous and strange financings.
Do We Know Enough About Napo Pharma’s SPAC To Invest In Jaguar Health?
Jaguar Health might merge part of its Napo Pharmaceuticals unit with a SPAC. What’s this mean for JAGX stock over the long haul?
JAGX Stock: Jaguar Health’s Napo EU to Go Public Via SPAC
JAGX stock may be slumping today, but new SPAC merger news could turn things around. Here is what you should know about the Napo EU deal now.
Proposed SPAC Merger Makes Jaguar Health Stock Intriguing
If you've been sitting on the sidelines when it comes to JAGX stock, an important meeting should give you the excuse you've been waiting for.
What You Need to Know About Jaguar Health Stock
Jaguar Health is showing better vital signs lately. However, there are still some things to consider before pouncing on JAGX stock.
JAGX Stock Surges Ahead of Jaguar Health SPAC Merger Meeting
Jaguar Health (JAGX) stock is on the rise Thursday after announcing a meeting concerning an upcoming SPAC merger in Italy.
Don’t Try to Tame Jaguar Health Stock As It Rips Higher
If you believe in the future of plant-based medical treatments, then a long position in JAGX stock could offer exposure to this technology.
JAGX Stock: 11 Things to Know as Jaguar Health Rockets Higher
JAGX stock is on the move today as Jaguar Health continues to gain attention. Here's what you should know about the biopharma play now.
JAGX Stock: 12 Things to Know About Fast-Moving Jaguar Health
JAGX shares are once again on the move this week. Here's what you should know about the maker of the antidiarrheal treatment Mytesi.
